Axim-Sapphire_Logo_-04 (1).png
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
21 févr. 2018 09h00 HE | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
FI-500.jpg
Fraser Institute News Release: Counterfeit pharmaceutical drugs put Canadian patients at risk
08 févr. 2018 05h00 HE | Fraser Institute
VANCOUVER, British Columbia, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Counterfeit pharmaceutical drugs pose a real risk to Canadians because they are showing up in brick-and-mortar pharmacies, not just on...
Dr. Paul Carney Join
Dr. Paul Carney Joins Biotica Pharmaceuticals as Neurologist Consultant and Scientific Advisor
03 janv. 2018 08h00 HE | Biotica Pharmaceuticals Inc.
Sarasota, FL, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Biotica Pharmaceuticals Inc. (Biotica), an early-stage biotech engaging in the discovery, development, and commercialization of cannabinoid-based...
Praxis Bioresearch Presents Positive Preclinical Data for Novel Prodrug Stimulant with Abuse-Deterrent Properties at ACNP Annual Meeting
07 déc. 2017 07h35 HE | Praxis Bioresearch
MENLO PARK, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Praxis Bioresearch, a biopharmaceutical company focused on the discovery and development of novel therapeutics for chronic neuropsychiatric and...
A New Program at Yal
A New Program at Yale Takes Aim at Opioid and other Substance Abuse using Entrepreneurship
15 nov. 2017 10h55 HE | Innovation to Impact
NEW HAVEN, Conn., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Yale University has announced a national program called Innovation to Impact to speed to market innovations that can directly fight substance...
AIR Experts to Prese
AIR Experts to Present at the American Public Health Association (APHA) Annual Meeting
02 nov. 2017 10h16 HE | American Institutes for Research
Washington, D.C, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Experts from the American Institutes for Research (AIR) will present at the American Public Health Association (APHA) Annual Meeting & Expo,...
CB Scientific’s (CBS
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
31 oct. 2017 08h00 HE | CB Scientific Inc
Denver, CO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems...
NS-Horizontal.png
Cuyahoga County Files Opioid Lawsuit Against Manufacturers and Distributors
27 oct. 2017 13h10 HE | Napoli Shkolnik PLLC
CLEVELAND, OH--(Marketwired - October 27, 2017) - Today, Cuyahoga County filed suit against manufacturers, distributors, and four individuals who were instrumental in promoting opioids for sale and...
Statement by U.S. Co
Statement by U.S. Conference of Mayors President and New Orleans Mayor Mitch Landrieu on President Trump’s Announcement About Opioid Epidemic
26 oct. 2017 17h01 HE | The U.S. Conference of Mayors
Washington, D.C, Oct. 26, 2017 (GLOBE NEWSWIRE) -- In response to President Trump’s announcement today declaring the opioid crisis a public health emergency, U.S. Conference of Mayors President and...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics® Secures $25 Million in Series C Financing
12 sept. 2017 08h03 HE | SPR Therapeutics, LLC
CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...